This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

19 May 2011

Goodwin Biotechnology and Rafagen Ink Deal for Biomanufacturing

Goodwin Biotechnology and RAFAGEN jointly announced their collaborative agreement for cell line engineering and biological contract manufacturing.

Goodwin Biotechnology, a contract biomanufacturing company, and Rafagen, a provider of engineered cell lines for protein and mAb production, have inked a collaborative agreement covering cell line engineering and biological contract manufacturing.


"By collaborating with Rafagen for cell-line engineering, we at GBI can expand our capabilities as a biological contract manufacturing organization and offer one-stop shopping," comments SooYoung Lee, Ph.D., svp at GBI.


"This enables our clients to overcome challenging projects by working from their cDNA to develop more robust and high-productivity cell lines that will not only scale up with greater efficiency, but by identifying cell lines with the highest level of efficacy, the end product will hopefully optimize patie

Related News